Skip to main content
Equibles
CHRS $1.20 +5.26%
CHRS logo

CHRS · Coherus Oncology, Inc.

Track CHRS — free

Use CHRS with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about CHRS

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$1.20 +0.06 (+5.26%) At close · Aug 14
Market Cap
$185.40M
Shares
154.50M
All earnings calls

Earnings call · FY2024 Q2

Coherus Oncology, Inc. Q2 FY2024 Earnings Call

Coherus Oncology, Inc. Q2 FY2024 Earnings Call

Concluded Aug 8, 2024
Aug 8, 2024 0 turns
Period
FY2024 Q2
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Research coverage

2 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $10.30M -82.5% YoY
Diluted EPS -$0.11
Net income -$12.92M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Aug 8, 2024 10-Q report Filed Aug 8, 2024

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Product And Service Other$6.51M +2412.4% YoY
Toripalimab$3.79M
Full-screen source Call document

Report a Problem

Category
Description
Email (optional, for follow-up)